In this issue:
Glucose time in range and diabetic retinopathy in type 2 diabetes
Aspirin for primary prevention in diabetes
Aspirin and CV events and bleeding in the elderly
Legacy effect of early glycaemic control on complications
Canagliflozin and renal outcomes in type 2 diabetes
Smoking cessation, bodyweight change, type 2 diabetes and mortality
Pharmacokinetics/pharmacodynamics of empagliflozin in young patients with type 2 diabetes
Impact of influenza on type 1 diabetes risk
Diet modification and maternal glucose and neonatal outcomes
Dorzagliatin improves glycaemic control and β-cell function in type 2 diabetes
Please login below to download this issue (PDF)